SGK3基因RNAi慢病毒载体的构建及其对乳腺癌MB-474细胞增殖和凋亡的影响

doi:10.13560/j.cnki.biotech.bull.1985.2017-0557

生物技术通报 ›› 2018, Vol. 34 ›› Issue (1): 247-252.doi: 10.13560/j.cnki.biotech.bull.1985.2017-0557

SGK3基因RNAi慢病毒载体的构建及其对乳腺癌MB-474细胞增殖和凋亡的影响

郭红艳¹, 高涵¹, 吴琦², 孙晓杰², 刘秀财¹, 赵立群³

1. 齐齐哈尔医学院生物化学教研室,齐齐哈尔 161006;
2. 齐齐哈尔医学院临床生化教研室,齐齐哈尔 161006;
3. 齐齐哈尔医学院第一附属医院医学影像CT室,齐齐哈尔 161041

收稿日期:2017-07-04 出版日期:2018-01-26 发布日期:2018-01-22
作者简介:郭红艳,女,博士,讲师,研究方向：肿瘤的分子生物学机制;E-mail：guohongyan5564@sohu.com
基金资助:
黑龙江省教育厅科学技术研究项目（2016-KYYWF-0836）

Construction of SGK3 Gene Lentiviral RNA Interference Vector and Effects on Cell proliferation and Apoptosis of Breast Cancer Cell Line MB-474

GUO Hong-yan¹, GAO Han¹, WU Qi², SUN Xiao-jie², LIU Xiu-cai¹, ZHAO Li-qun³

1. Department of Biochemistry,Qiqihar Medical College,Qiqihar 161006;
2. Department of Clinical Biochemistry,Qiqihar Medical College,Qiqihar 161006;
3. Medical Imaging Department,the First Affiliated Hospital of Qiqihar Medical College,Qiqihar 161041

Received:2017-07-04 Published:2018-01-26 Online:2018-01-22

摘要/Abstract

摘要： 旨在构建SGK3基因RNAi慢病毒表达载体,观察其对人乳腺癌细胞MB-474增殖和凋亡的影响。构建靶向SGK3的shRNA序列慢病毒载体,将其转染至人乳腺癌MB-474细胞以沉默SGK3基因,Real-time PCR、Western bloting方法检测MB-474细胞SGK3 mRNA及蛋白表达,MTT法和流式细胞术检测SGK3基因沉默对MB-474细胞增殖、细胞周期和凋亡的影响。测序结果显示,成功构建4组SGK3基因RNAi慢病毒表达载体,经 293T 细胞包装,病毒滴度为（3-8）×10⁸ TU/mL;将慢病毒转染MB-474细胞后,Real-time PCR、Western bloting结果显示,干扰组SGK3的表达水平较对照组均降低,且PGC-LV3-SGK3-1序列对其干扰效果最佳,SGK3基因沉默可抑制MB-474细胞增殖、促进凋亡,但其对细胞周期进程无明显影响。成功构建靶向SGK3基因的RNAi慢病毒载体,SGK3基因沉默可影响乳腺癌细胞增殖和凋亡等生物学行为。

关键词: RNAi慢病毒, SGK3, 细胞增殖, 细胞凋亡

Abstract: This study is aimed to construct the lentiviral RNA interference（RNAi）vector of SGK3 gene,and to observe its effect on the proliferation and apoptosis of human breast cancer cell line MB-474. The lentiviral vector of shRNA sequence targeting SGK3 was constructed and transfected into human breast cancer MB-474 cells to silence the SGK3 gene. The expression of SGK3 mRNA and protein in transfected MB-474 cells was detected by real-time PCR and Western bloting,and the effect of SGK3 gene silencing on the proliferation,cell cycle and apoptosis of MB-474 cells was detected by MTT assay and flow cytometry. Gene sequencing showed that 4 RNAi lentiviral vectors targeting the SGK3 gene were successfully constructed. The lentiviral vectors were packed successfully by 293T cells and the virus titer was（3-8）×10⁸ TU/mL. After the recombinant lentiviral vector was transfected into MB-474 cells,real-time PCR and Western bloting demonstrated that the expression of SGK3 in interference group was lower than that of control group. Among the 4 lentiviral vectors,the one with best interference effect is the PGC-LV3-SGK3-1 sequence. SGK3 silencing inhibited MB-474 cell proliferation and promoted apoptosis,but had no significant effect on cell cycle progression. In short,RNAi lentivirus vector targeting SGK3 gene was successfully constructed,and SGK3 gene silencing affected cell proliferation and apoptosis of breast cancer.

Key words: RNAi lentivirus, SGK3, cell proliferation, apoptosis

郭红艳, 高涵, 吴琦, 孙晓杰, 刘秀财, 赵立群. SGK3基因RNAi慢病毒载体的构建及其对乳腺癌MB-474细胞增殖和凋亡的影响[J]. 生物技术通报, 2018, 34(1): 247-252.

GUO Hong-yan, GAO Han, WU Qi, SUN Xiao-jie, LIU Xiu-cai, ZHAO Li-qun. Construction of SGK3 Gene Lentiviral RNA Interference Vector and Effects on Cell proliferation and Apoptosis of Breast Cancer Cell Line MB-474[J]. Biotechnology Bulletin, 2018, 34(1): 247-252.

参考文献

[1] Liu H, Li C, Shen C, et al. MiR-212-3p inhibits glioblastoma cell proliferation by targeting SGK3[J]. J Neurooncol, 2015, 122（3）：431-439.
[2] Hou M, Lai Y, He S, et al. SGK3（CISK）may induce tumor angiogenesis（Hypothesis）[J]. Oncol Lett, 2015, 10（1）：23-26.
[3] Wang Y, Zhou D, Chen S. SGK3 is an androgen-inducible kinase promoting prostate cancer cell proliferation through activation of p70 S6 kinase and up-regulation of cyclin D1[J]. Mol Endocrinol, 2014, 28（6）：935-948.
[4] Gasser JA, Inuzuka H, Lau AW, et al. SGK3 mediates INPP4B-dependent PI3K signaling in breast cancer[J]. Mol Cell, 2014, 56（4）：595-607.
[5] 郭红艳, 孙晓杰, 刘秀财, 等. 蛋白激酶SGK3与乳腺癌临床病理相关性研究[J]. 现代预防医学, 2016, 43（6）：1142-1145.
[6] 郭红艳, 孙晓杰, 刘秀财, 等. 蛋白激酶SGK3过表达对乳腺癌细胞株MDA-MB-231影响的研究[J]. 中华肿瘤防治杂志, 2016, 23（24）：1601-1606.
[7] Hausmann S, Brandt E, Köchel C, et al. Loss of serum and glucocorticoid-regulated kinase 3（SGK3）does not affect proliferation and survival of multiple myeloma cell lines[J]. PLoS One, 2015, 10（4）：e0122689.
[8] Bago R, Sommer E, Castel P, et al. The hVps34-SGK3 pathway alleviates sustained PI3K/Akt inhibition by stimulating mTORC1 and tumour growth[J]. EMBO J, 2016, 35（17）：1902-1922.
[9] Liu M, Chen LL, Chan TH, et al. Serum and glucocorticoid kinase 3 at 8q13. 1 promotes cell proliferation and survival in hepatocellular carcinoma[J]. Hepatology, 2012, 55（6）：1754-1765.
[10] Scortegagna M, Lau E, Zhang T, et al. PDK1 and SGK3 contribute to the growth of BRAF mutant melanomas and are potential therapeutic targets[J]. Cancer Res, 2015, 75（7）：1399-1412.
[11] Xu J, Wan M, He Q, et al. SGK3 is associated with estrogen receptor expression in breast cancer[J]. Breast Cancer Res Treat, 2012, 134（2）：531-541.
[12] Sun XJ, Liu XC, Liu B, et al. Serum-and glucocorticoid-regulated protein kinase 3（SGK3）overexpression promotes tumor development and aggression in breast cancer cells[J]. ONCOL LETTERS, 2016, 12：437-444.
[13] Bruhn MA, Pearson RB, Hannan RD, et al. AKT-independent PI3-K signaling in cancer-emerging role for SGK3[J]. Cancer Manag Res, 2013, 5：281-292.
[14] Bruhn MA, Pearson RB, Hannan RD, Sheppard KE. Second AKT：the rise of SGK in cancer signaling[J]. Growth Factors, 2010, 28（6）：394-408.
[15] Wang Y, Zhou D, Phung S, et al. SGK3 sustains ERα signaling and drives acquired aromatase inhibitor resistance through maintaining endoplasmic reticulum homeostasis[J]. Proc Natl Acad Sci U S A, 2017, 114（8）：E1500-E1508.

SGK3基因RNAi慢病毒载体的构建及其对乳腺癌MB-474细胞增殖和凋亡的影响

Construction of SGK3 Gene Lentiviral RNA Interference Vector and Effects on Cell proliferation and Apoptosis of Breast Cancer Cell Line MB-474

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	杨昕冉, 王建芳, 马鑫浩, 昝林森. m⁶A甲基化修饰相关酶基因在牛脂肪生成中的表达分析[J]. 生物技术通报, 2022, 38(7): 70-79.
[2]	尹晓梦, 曹雪玮, 王富军, 赵健, 张惠展. 雷公藤红素与凋亡蛋白突变体通过强化Nur77诱发凋亡通路发挥协同抗肿瘤作用[J]. 生物技术通报, 2020, 36(7): 119-129.
[3]	杨雷, 叶洲杰, 李兆龙, 沈阳坤, 傅雅娟. 利用电转的方法对T细胞TET2基因敲除并探讨TET2对T细胞增殖的影响[J]. 生物技术通报, 2020, 36(1): 229-237.
[4]	朱平, 杜力杰, 孟昆, 薛娟, 杨瑾, 李姗. 三型分泌系统效应蛋白调控细胞凋亡和焦亡的研究进展[J]. 生物技术通报, 2019, 35(4): 178-187.
[5]	胡建燃, 李平, 铁军, 金山. 紫丁香花精油的抗氧化和抗肿瘤活性研究[J]. 生物技术通报, 2019, 35(12): 16-23.
[6]	陈子涵, 刘金娟. 六种食用菌体外抗氧化及抗细胞增殖活性研究[J]. 生物技术通报, 2019, 35(11): 104-108.
[7]	李平, 张桂萍 ,胡建燃. 连翘总黄酮对胃癌细胞MGC80-3增殖的影响[J]. 生物技术通报, 2018, 34(6): 199-203.
[8]	翟逸舟 ,卢美雅 ,赵健 ,王富军. 白树毒素融合蛋白的筛选及其抗肿瘤作用和凋亡途径研究[J]. 生物技术通报, 2018, 34(6): 204-212.
[9]	胡建燃,李平,雷海英,刘贤瑞. 潞党参多糖对宫颈癌细胞SiHa增殖和迁移的影响[J]. 生物技术通报, 2017, 33(5): 159-163.
[10]	邓雨青, 李平, 周彦, 熊克才, 李中安. 植物细胞程序性死亡检测技术研究进展[J]. 生物技术通报, 2017, 33(3): 52-57.
[11]	侯欢欢, 卢佳, 章纬菁, 黄芳任文华. 少棘蜈蚣抗菌肽scolopin 2的克隆、表达与抗癌机制研究[J]. 生物技术通报, 2016, 32(9): 172-178.
[12]	韩亚伟, 王西华, 陈利平, 时桂芹, 孙丽萍, 周文珊. NNK对NCTC 1469细胞毒性作用的研究[J]. 生物技术通报, 2015, 31(9): 218-223.
[13]	齐仁立, 黄金秀, 龙定彪, 黄萍. MicroRNA与NF-κB调控的细胞凋亡[J]. 生物技术通报, 2015, 31(5): 27-31.
[14]	刘凤霞,刘文娟,李建勇,陈胜国. ERK1/2在食管鳞状细胞癌中促进细胞增殖、抑制凋亡及其调控机制的研究[J]. 生物技术通报, 2015, 31(10): 242-248.
[15]	何东洋,马超,高振月,王淑珍,陈依军. 人源CD137L基因在不同表达系统中表达效率的比较[J]. 生物技术通报, 2014, 0(9): 178-184.